Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XEMA
Lappeenranta, South Karelia, Finlandxemagroup.com ↗
- Ownership
- Private
- Employees
- ~32
- Development stage
- Other
01
Overview
XEMA is a long-established manufacturer of ELISA and rapid test kits for clinical diagnostics, veterinary testing, food quality control, environmental monitoring, and forensic applications. The company produces its own monoclonal antibodies and recombinant proteins used as key reagents in these tests. Their products are distributed globally to other diagnostic companies and research organizations[1][4].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Monoclonal antibodyRecombinant proteinSmall molecule (for diagnostic reagents)
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Hytest OyFitzgerald Industries InternationalZAO “Vector-Best”NPO “DS”Granum CompanyGlobe Diagnostic Srl.Orgenics
Beyond the preview
Go deeper on XEMA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XEMA.